STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$19.00
0.66 (3.60%)
▲
5d:
+3.32%
30d:
+1.12%
90d:
+38.18%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: STVN shows positive signals but monitor for confirmation. Market pricing in 1.0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: STVN shows positive signals but monitor for confirmation. Market pricing in 1.0% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.52
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$19.57
2.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $19.00, which is considered extended relative to its 30-day fair value range of $17.13 to $18.58. The stock's valuation (Forward PE: 22.7) is in line with its historical norms (22.0). At these levels, the market is pricing in 1.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is approaching resistance at $19.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: STVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.45 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is approaching resistance at $19.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: STVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.45 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.13 -
$18.58
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 28.7% below Wall St target ($24.45)
- NEUTRAL: Market pricing in 1.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$17.13 -
$18.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.50
Resistance Level
$19.02
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.67
Wall Street Target
$24.45
(+28.7%)
Revenue Growth (YoY)
6.6%
Earnings Growth (YoY)
2.9%
Profit Margin
11.8%
Valuation Premium vs History
+1.0% premium
PE vs Historical
22.7 vs 22.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.0%
(market-implied from PE analysis)
1-Year Target
$19.19
(+1%)
2-Year Target
$19.38
(+2%)
3-Year Target
$19.58
(+3%)
3-Yr Target (if PE normalizes)
(PE: 23→22)
PE COMPRESSION
$18.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.7, Growth: 18.9%)
$31.96
(+68%)
Base:
(SPY PE: 21.8, Growth: 18.9%)
$30.70
(+62%)
Bear:
(PE: 18.5, Growth: 18.9%)
$26.10
(+37%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 31.62 | Current EPS (TTM): $0.58
Bull Case
$29.15
(+53%)
Analyst growth 44.5%, PE expands to 34.8
Base Case
$26.50
(+40%)
Market implied 44.5%, PE stable at 31.6
Bear Case
$12.47
(-34%)
Severe decline -20.0%, PE contracts to 26.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 10:20 PM ET
Data refreshes hourly during market hours. Next update: 11:20 PM
Data refreshes hourly during market hours. Next update: 11:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
